1.Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DSC et al: Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine 2020.
2.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395(10223):497–506.
3.Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y et al: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020, 395(10223):507–513.
4.Drosten C, Günther S, Preiser W, van der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA et al: Identification of a novel coronavirus in patients with severe acute respiratory syndrome. The New England journal of medicine 2003, 348(20):1967–1976.
5.Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. The New England journal of medicine 2012, 367(19):1814–1820.
6.Coronavirus disease (COVID–2019) situation reports [https://www.who.int/emergencies/diseases/novel-coronavirus–2019/situation-reports]
7.Ministry of Health eportal [https://www.moh.gov.om/en/web/adolescent-health-conference/ministry-of-health]
8.Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y et al: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020.
9.Oman Ministry of Health: The national clinical management pathways for hospitalized patients with COVID 19. In.; 2020.
10.Higher Mortality Rate in Ventilated COVID–19 Patients in Large Sample
11.Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z: Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID–19). Journal of General Internal Medicine 2020, 35(5):1545–1549.
12.Coronavirus Is the Last Thing the Middle East Needs Right Now [https://nymag.com/intelligencer/2020/03/coronavirus-is-the-last-thing-themiddle]
13.The private sector and universal health coverage [https://www.who.int/bulletin/volumes/97/6/18–225540/en/]
14.Hussain A, Bhowmik B, do Vale Moreira NC: COVID–19 and diabetes: Knowledge in progress. Diabetes research and clinical practice 2020, 162:108142–108142.
15.Ferrari R, Di Pasquale G, Rapezzi C: Commentary: What is the relationship between Covid–19 and cardiovascular disease? Int J Cardiol 2020, 310:167–168.
16.Hussain A, Bhowmik B, do Vale Moreira NC: COVID–19 and diabetes: Knowledge in progress. Diabetes Research and Clinical Practice 2020, 162:108142.
17.Onder G, Rezza G, Brusaferro S: Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID–19 in Italy. JAMA 2020, 323(18):1775–1776.
18.IDF Diabetes Atlas,9th edn. [https://diabetesatlas.org/en/resources/]
19.McDonald HI, Nitsch D, Millett ERC, Sinclair A, Thomas SL: New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabet Med 2014, 31(5):606–614.
20.Knapp S: Diabetes and Infection: Is There a Link? - A Mini-Review. Gerontology 2013, 59(2):99–104.
21.Leung WK, To K-f, Chan PKS, Chan HLY, Wu AKL, Lee N, Yuen KY, Sung JJY: Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection1 1The authors thank Man-yee Yung, Sara Fung, Dr. Bonnie Kwan, and Dr. Thomas Li for their help in retrieving patient information. Gastroenterology 2003, 125(4):1011–1017.
22.Memish ZA, Perlman S, Van Kerkhove MD, Zumla A: Middle East respiratory syndrome. Lancet 2020, 395(10229):1063–1077.
23.Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, Zhang Z: D-dimer levels on admission to predict in-hospital mortality in patients with Covid–19. Journal of thrombosis and haemostasis: JTH 2020, 18(6):1324–1329.
24.Ji DaZ, Dawei and Chen, Zhu and Xu, Zhe and Zhao, Peng and Zhang, Mingjie and Zhang, Lunqing and Cheng, Gregory and Wang, Yudong and Yang, Guang and Liu, Hongxia and Li;: Clinical Characteristics Predicting Progression of COVID–19. The Lancet 2020.
25.Koperdanova M, Cullis JO: Interpreting raised serum ferritin levels. BMJ: British Medical Journal 2015, 351:h3692.
26.Kangelaris KN, Ware LB, Wang CY, Janz DR, Zhuo H, Matthay MA, Calfee CS: Timing of Intubation and Clinical Outcomes in Adults With Acute Respiratory Distress Syndrome. Crit Care Med 2016, 44(1):120–129.
27.de Wit E, van Doremalen N, Falzarano D, Munster VJ: SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology 2016, 14(8):523–534.
28.Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, Skipper CP, Nascene AA, Nicol MR, Abassi M et al: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid–19. New England Journal of Medicine 2020.
29.Wang Y, Jiang W, He Q, Wang C, Wang B, Zhou P, Dong N, Tong Q: Early, low-dose and short-term application of corticosteroid treatment in patients with severe COVID–19 pneumonia: single-center experience from Wuhan, China. medRxiv 2020:2020.2003.2006.20032342.
30.University of Oxford: Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID–19. In. UK; 2020.